Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use

類似資料

• Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors
  著者:: Sarayut Lahnwong, 等
  出版事項: (2018-07-01)
• Sodium–glucose co-transporter-2 inhibitors - empagliflozin and dapagliflozin as future therapy for Alport Syndrome, literature review
  著者:: Magdalena Kłusek, 等
  出版事項: (2024-07-01)
• Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature
  著者:: Alexis Diaz-Ramos, 等
  出版事項: (2019-09-01)
• Sodium-Glucose Cotransporter-2 Inhibitors-from the Treatment of Diabetes to Therapy of Chronic Heart Failure
  著者:: Dominik Kurczyński, 等
  出版事項: (2022-07-01)
• Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
  著者:: Annamaria Mascolo, 等
  出版事項: (2022-09-01)